Ivermectin treatment in rosacea: How novel smartphone technology can support monitoring rosacea-associated signs and symptoms.
Demodex
Scarletred®vision
erythema
rosacea
skin texture
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
revised:
16
09
2022
received:
17
06
2022
accepted:
27
09
2022
pubmed:
1
10
2022
medline:
5
11
2022
entrez:
30
9
2022
Statut:
ppublish
Résumé
Rosacea lessens patients' quality of life not only by visible symptoms like erythema, papules, and pustules but also by invisible symptoms like stinging, burning, and dryness. Ivermectin 1% cream has recently been introduced as an efficient therapy for papules and pustules in rosacea patients. To investigate the potential of ivermectin 1% cream to improve rosacea-associated erythema and invisible symptoms by combining established questionnaires with the novel photography and analysis tool Scarletred®Vision. We performed an open monocentric pilot study including 25 Caucasian patients presenting with moderate to severe rosacea with erythema, less than 10 papules and/or pustules, and ≥ 15 Demodex mites/cm
Substances chimiques
Ivermectin
70288-86-7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15869Informations de copyright
© 2022 The Authors. Dermatologic Therapy published by Wiley Periodicals LLC.
Références
Schaller M, Dirschka T, Lonne-Rahm SB, et al. The importance of assessing burning and stinging when managing rosacea: a review. Acta Derm Venereol. 2021;101:adv00584.
Forton FM, De Maertelaer V. Two consecutive standardized skin surface biopsies: an improved sampling method to evaluate Demodex density as a diagnostic tool for rosacea and Demodicosis. Acta Derm Venereol. 2017;97(2):242-248.
Forton F, De Maertelaer V. Erythematotelangiectatic rosacea may be associated with a subclinical stage of demodicosis: a case-control study. Br J Dermatol. 2019;181(4):818-825.
Galderma, Fachinformation Soolantra 10 mg/g Creme, Accessed January 2017 (German).
Schaller M, Gonser L, Belge K, et al. Dual anti-inflammatory and anti-parasitic action of topical ivermectin 1% in papulopustular rosacea. J Eur Acad Dermatol Venereol. 2017;31(11):1907-1911.
Schaller M, Kemény L, Havlickova B, et al. A randomized phase 3b/4 study to evaluate concomitant use of topical ivermectin 1% cream and doxycycline 40-mg modified-release capsules, versus topical ivermectin 1% cream and placebo in the treatment of severe rosacea. J Am Acad Dermatol. 2020;82(2):336-343.
Tan J, Almeida LM, Bewley A, et al. Updating the diagnosis, classification and assessment of rosacea: recommendations from the global ROSacea COnsensus (ROSCO) panel. Br J Dermatol. 2017;176(2):431-438.
Schaller M, Almeida LMC, Bewley A, et al. Recommendations for rosacea diagnosis, classification and management: update from the global ROSacea COnsensus 2019 panel. British Journal of Dermatology. 2020;182(5):1269-1276.
Dall'Oglio F, Lacarrubba F, Luca M, et al. Clinical and erythema-directed imaging evaluation of papulo-pustular rosacea with topical ivermectin: a 32 weeks duration study. J Dermatolog Treat. 2019;30(7):703-707.
Scarletred®Vision, Accessed October 25, 2021. https://www.scarletred.com/products/vision
Partl R, Jonko B, Schnidar S, et al. 128 SHADES OF RED: objective remote assessment of radiation dermatitis by augmented digital skin imaging. Stud Health Technol Inform. 2017;236:363-374.
Tan J, Liu H, Leyden JJ, Leoni MJ. Reliability of clinician erythema assessment grading scale. J Am Acad Dermatol. 2014;71(4):760-763.
Tan J, Leoni M. Erythema of rosacea: validation of Patient's self-assessment grading scale. J Drugs Dermatol. 2015;14(8):841-844.
Arabi PM, Joshi G, Vamsha DN. Performance evaluation of GLCM and pixel intensity matrix for skin texture analysis. Perspectives in Science. 2016;8:203-206.
Mostaço-Guidolin LB, Ko ACT, Wang F, et al. Collagen morphology and texture analysis: from statistics to classification. Sci Rep. 2013;3(1):2190.
Forton FMN. The pathogenic role of Demodex mites in rosacea: a potential therapeutic target already in Erythematotelangiectatic rosacea? Dermatol Ther (Heidelb). 2020;10(6):1229-1253.
Huang HP, Hsu CK, Lee JY. Rosacea with persistent facial erythema and high Demodex density effectively treated with topical ivermectin alone or combined with oral carvedilol. Dermatol Ther. 2021;34(2):e14899.
Darji K, Burkemper NM. Pityriasis Folliculorum: response to topical Ivermectin. J Drugs Dermatol. 2017;16(12):1290-1292.
Dall'Oglio F, Lacarrubba F, Micali G. Erythema-directed digital photography and colorimeter scores correlate with rosacea erythema evaluation in patients under treatment with topical ivermectin. Dermatol Ther. 2021;34(3):e14920.